Cancer News: Breast
In a 25-year follow-up report from a Canadian screening program, annual mammography did not reduce breast cancer mortality in women ages 40-59. This sparked further an ongoing debate on the common practice and its effects.
A new discovery showed that invasive bladder cancer and some breast cancers have genetic similarities. This could lead to new therapies and diagnostic aids.
The US FDA has approved trastuzumab emtansine (or T-DM1) for HER2-positive metastatic breast cancer treatment following trastuzumab and taxanes chemotherapy.
Researchers identified a protein that can be targeted for treating triple-negative breast cancer, the most aggressive form of the disease. More testing is necessary before trying this assumption in a clinical trial.
A comprehensive consensus guideline for breast cancer surgery has been released by major societies, aiming to improve the course of treatment and reduce costs.
Invasive lobular carcinoma is the second most common type of breast cancer. Latest research shows it may be a good candidate for personalized treatment.
Fatigue is a common side effect of radiation therapy. New research shows yoga helps breast cancer patients regulate stress hormones and overcome it more easily.
Research among more than 4,000 women showed that high levels of a vitamin D related metabolite could be correlated with 50% improved survival rates.
A new clinical test aims to predict survival but also the possible treatment failure for breast cancer patients. It could be available in two years.
A new study by researchers from US private practices and academic medical centers shows that more women are receiving breast reconstruction after mastectomies.
Breast cancer patients, whose tumor has spread to just a few lymph nodes under their arm, may benefit if they have radiation therapy after mastectomy.
The benefit of 10-year vs 5-year hormone therapy for ER+ breast cancer was genetically analyzed, helping identify the women who should receive longer treatment.
According to researchers, women of any age can reduce the risk of breast cancer, by participating in physical activity every day, for an hour or more.
Obesity & diabetes negatively affect outcomes in breast cancer patients who receive chemotherapy as primary treatment before surgery (neoadjuvant chemotherapy).
Women with a BRCA mutation, with gynecologic cancers which did not respond to other treatments, had improved outcomes & minimal side effects from an oral drug.
Women at high risk of breast and ovarian cancer due to BRCA1 mutation may be able to use already available drugs instead of undergoing irreversible surgery.
The 2nd most common breast cancer subtype is a unique disease and appears to be a good candidate for a targeted treatment approach, according to new research.
A clinical trial for a breast cancer drug nearly doubled the time before disease got worse, but impact on overall survival was not shown to be significant.
Women and their doctors are concerned that fertility treatments may increase possibility of breast cancer, but this was not confirmed at a large 30-year study.
Researchers are beginning to understand how pregnancy can reduce breast cancer risk, by comparing genetic materials of women who had and had not given birth.
The risk of developing a primary lung tumor for women who had radiotherapy for breast cancer increases with the radiation amount, according to researchers.
No repeat lumpectomy will be needed in 96% of cases, based on unique lab testing during the operation, which will enable surgeons remove all cancerous tissue.
A new compound active against triple-negative breast cancer has been developed, which offers increased scientific understanding of this very aggressive cancer.
A new non-invasive blood based test can detect breast cancer recurrence and may also predict treatment outcomes. It is based on 10 breast-cancer specific genes.
Women who eat a lot of fat (saturated fat in particular), may be at higher risk of certain breast cancer types, as per research on this controversial topic.
Nearly 1 in 3 breast cancer survivors who were working when they began treatment, were unemployed 4 years later, especially if they received chemotherapy.
A new study indicates that sleep disruption may lead to weaker immune function or impaired hormonal stress responses. The mechanism remains unclear, however.
Scientists have identified 17 "high-priority" chemicals that women should avoid in order to reduce risk of breast cancer, and show how to detect their presence.
A new study associated obesity with a 34% higher risk of death in pre-menopausal women with early breast cancer susceptible to higher hormone estrogen levels.
Breast cancer patients can benefit from a brief, 5-week psychological intervention after surgery, in dealing with the stress of the diagnosis and operation.